Blood cancer patients with penicillin allergy may get safer antibiotics
NCT ID NCT06967467
First seen Nov 17, 2025 · Last updated Jun 16, 2026 · Updated 26 times
Summary
This study looks at how doctors and patients feel about using a new tool to choose antibiotics for people with blood cancer who have a reported penicillin allergy. The goal is to find out what might make it hard or easy to use this tool in everyday hospital care. About 80 patients and their doctors will answer questionnaires to measure how acceptable and practical the tool is.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BETA LACTAM ALLERGY IN PATIENTS WITH A HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.